ANAHEIM, Calif., Nov. 22, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company has been recognized with an "Everyday Hero" award from the NephCure Foundation for its "tireless efforts" to advance science and research in the field of nephrology and to also promote educational efforts related to the treatment of proteinuria in patients with kidney disease who are suffering from nephrotic syndrome. The NephCure Foundation is a charity organization committed exclusively to supporting research seeking the cause of the potentially debilitating kidney disease Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic Syndrome, improving treatment and finding a cure.
"Questcor is honored to have received this recognition from NephCure," said Steve Cartt, Chief Operating Officer of Questcor. "We feel strongly about supporting research and educational initiatives that will positively impact patients with kidney disease and the nephrology community as a whole. Our flagship product, Acthar, is an FDA-approved prescription medication that is used by an increasing number of nephrologists to induce remission of proteinuria in patients who are suffering from certain types of nephrotic syndrome. We are proud to support the nephrology community through the funding of research, education and other important initiatives."
Henry Brehm, executive director of NephCure, said the organization decided to recognize Questcor because of its support for a patient population that has a significant unmet need. "Questcor has proven through its actions that it is committed to education, assistance and research that strive to improve the quality of life for patients suffering from nephrotic syndrome, until a cure can be found. We applaud their dedication and commitment to our community."
Questcor was honored at NephCure's annual "Countdown for a Cure" fundraiser held on November 21 st in New York City. The event raises money and awareness for its efforts to fund medical research and education programs in the fight against the kidney disease. Since its inception nine years ago, "Countdown To A Cure" has raised over $3 million for The NephCure Foundation.About Proteinuria and Nephrotic Syndrome Proteinuria (excess urinary protein) can be caused by a variety of diseases and disorders of the kidney. A significant deterioration in kidney function can result in very high levels of proteinuria, a condition associated with nephrotic syndrome. Left untreated, nephrotic syndrome may lead to end stage renal disease, which typically requires life-long dialysis treatments. Types of kidney disease that can lead to nephrotic syndrome and end-stage renal disease include:
- Idiopathic Membranous Nephropathy (MN)
- Focal Segmental Glomerulosclerosis (FSGS)
- Minimal Change Disease (MCD)
- Membranoproliferative Glomerulonephritis (MPGN)
- Lupus Nephritis (LN)
- IgA Nephropathy (IgA)
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV